Annual report pursuant to Section 13 and 15(d)

Stock-based Compensation (Tables)

v3.24.1
Stock-based Compensation (Tables)
12 Months Ended
Dec. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Stock-based Compensation Expense

We recorded stock-based compensation expense for the years ended December 31, 2023 and 2022 as follows:

  

    2023     2022  
    Year Ended
December 31,
 
    2023     2022  
Research and development   $ 363,956     $ 2,895,653  
General and administrative     2,007,258       5,933,060  
Total   $ 2,371,214     $ 8,828,713  
Schedule of Restricted Stock Awards (“RSAs”) Activity

The following table summarizes our restricted stock award (RSA) activity during the years ended December 31, 2022 and 2023:

 

    Number of
shares
    Weighted-
average
grant-date fair
value per share
 
Unvested as of January 1, 2022     4,555     $ 157.81  
Granted     9,358       74.27  
Forfeited     (1,676 )     110.62  
Vested and issued     (9,142 )     100.88  
Unvested as of December 31, 2022     3,095       94.44  
Granted     10,750       14.59  
Forfeited     (1,250 )     133.00  
Cancelled     (2,555 )     22.13  
Vested and issued     (8,790 )     24.44  
                 
Unvested as of December 31, 2023     1,250     $ 9.26  
Schedule of Restricted Stock Units (“RSUs”) Activity

The following table summarizes our restricted stock unit (RSU) activity during the years ended December 31, 2022 and 2023:

 

    Number of
shares
    Weighted-
average
grant-date fair
value per share
 
Outstanding at January 1, 2022     22,008     $ 155.29  
Granted     121,439       61.50  
Forfeited     (3,431 )     101.73  
Cancelled     (1,876 )     171.58  
Issued     (2,399 )     79.07  
Outstanding at December 31, 2022     135,741       73.81  
Granted     116,078       14.18  
Forfeited     (12,296 )     21.69  
Cancelled     (16,801 )     71.36  
                 
Outstanding at December 31, 2023     222,722       45.82  
Vested and unissued     (115,145 )     71.90  
                 
Unvested at December 31, 2023     107,577     $ 17.90  
Schedule of Warrants Activity

The following table summarizes our warrant activity during the years ended December 31, 2022 and 2023.

 

    Total warrants outstanding     Weighted average exercise price     Weighted average remaining contractual life (in years)  
Outstanding as of January 1, 2022     15,190     $ 213.22          
Expired     (907 )     343.28                     
Outstanding as of December 31, 2022     14,283       205.01       0.9  
Granted     173,007       19.27          
Expired     (6,783 )     266.96          
Not exercisable    

(7,500

)    

7.40

         
Outstanding and exercisable as of December 31, 2023     173,007     $ 25.41       2.2  
Warrant [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Stock Option Warrant Valuation Assumption

We used the Black-Scholes option pricing model to calculate the grant date fair value of the two warrants with the following assumptions:

 

Average risk-free rate of interest     4.32-4.88 %
Expected term (years)     2.003.00  
Expected stock price volatility     82.85-108.47 %
Dividend yield     0 %
Share-Based Payment Arrangement, Option [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Stock Option Activity

The following table summarizes our stock option activity during the years ended December 31, 2022 and 2023:

 

    Total options Outstanding     Weighted average exercise price     Weighted average remaining contractual life (in years)  
Outstanding as of January 1, 2022     8,943     $ 341.34          
Options granted     -                  
Forfeited     -                  
Outstanding as of December 31, 2022     8,943       341.34       2.6  
Options granted     -                  
Forfeited or expired     (1,951 )     257.28          
Outstanding and exercisable as of December 31, 2023     6,992     $ 364.72       2.1